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“Our research shows that people are playing 
Russian Roulette with their lives because only 
the chemist creating the synthetic cannabinoid 
really knows what is in it,” said Dr. Eric Wish, 
director of the Coordinating Center for the 
National Institute on Drug Abuse (NIDA) 
funded National Drug Early Warning System 
(NDEWS) located at the University of Mary-
land, College Park. “We have found very dif-
ferent metabolites in different sites across the 
country and even in the same site over time.” 
 
 
 
 
 
Health effects from the drug can be life-
threatening and include: 
 Severe agitation & anxiety 
 Racing heartbeat & higher blood pressure 
 Nausea & vomiting 
 Muscle spasms, seizures & tremors 
 Intense hallucinations & psychosis 
 Suicidal & harmful thoughts or actions 
The American Association of Poison Control 
Centers (AAPCC) warned April 23 that a 
group of dangerous new synthetic canna-
binoids have led to a dramatic spike in poi-
son center exposure calls in the U.S. 
From Jan. 1 through April 22, 2015, poison 
centers received 1,900 exposure calls from 
people seeking help for adverse reactions to 
these drugs, almost four times the rate of 
calls received in 2014. In New York, the 
Governor issued a health alert saying emer-
gency departments reported seeing more 
than 160 patients in a nine day period. Ala-
bama has saw 317 synthetic cannabinoid-
related emergency department visits in an 18 
day window as of April 20. Other states such 
as New Jersey, Mississippi, Texas, Florida 
and Arizona have also seen dramatic increas-
es in reports, signaling a national problem. 
Synthetic drugs likely are underreported in 
Iowa, because there is no requirement.  
Still, the Iowa Poison Control Center says 
after receiving only two synthetic drug ex-
posure calls during the previous three 
months, in April alone it received 10 syn-
thetic drug exposure calls, plus a report of 
one synthetic drug-related death of a teen. 
Physicians can experience difficulty trying to 
determine the cause of severe medical prob-
lems seen in users when they present to 
emergency departments due to the wide vari-
ety of chemicals used to make these drugs. 
“Synthetic drugs present a potentially fatal 
risk not well recognized by people consuming 
these products,” said AAPCC President Jay 
Schauben, PharmD, DABAT, FAACT. “The 
recent death of five people suspected of using 
this category of drugs underscores the urgen-
cy of controlling these drugs and educating 
the public of their dangers.” 
The Centers for Disease Control and Preven-
tion (CDC) and AAPCC have conducted 
public health surveillance using data stored in 
the National Poison Data System (NPDS) 
since 2000 to help identify and characterize 
emerging public health threats. 
"We're greatly concerned by the rise in calls 
to poison centers regarding synthetic canna-
binoids," said Dr. Amy Wolkin, chief of the 
CDC’s Health Studies Branch. "The percep-
tion that these drugs are harmless is danger-
ous. People and hospitals need to be aware of 
the potential harm they can do." 
WARNINGS ISSUED ON REEMERGING SYNTHETIC DRUGS 
OTHER SYNTHETIC DRUG NEWS 
A synthetic cathinone called “flakka” (alpha-PVP) is surging in parts of the 
U.S.  NIDA says vaporizing may lead to overdose.  “Flakka,” can cause a 
condition called “excited delirium” that involves extreme stimulation, para-
noia and hallucinations that can lead to violent aggression and self-injury. 
 
 
 
 
 
 
“The drug has been linked to deaths by suicide as well as heart attack.  It can 
also dangerously raise body temperature and lead to kidney damage or fail-
ure,” NIDA explains on its website: http://www.drugabuse.gov/drugs-
abuse/emerging-trends.  
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